Search Results - Xuchen Cao
- Showing 1 - 1 results of 1
-
1
Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States by Gengwei Huo, Ying Song, Wenjie Liu, Xuchen Cao, Peng Chen
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book